Meeting
2021 ASCO Annual Meeting
A phase 1 study to evaluate chimeric antigen receptor (CAR) T cells incorporating a chlorotoxin tumor-targeting domain for patients with MMP2+ Recurrent or progressive glioblastoma (NCT04214392).
Authors
Behnam Badie
City of Hope National Medical Center, Duarte, CA
Behnam Badie , Michael E Barish , Ammar Chaudhry , Massimo D'Apuzzo , Stephen J. Forman , Jana Portnow , Shirong (Sean) Wang , Julie A Ressler , Jennifer Simpson , Julie Kilpatrick , Paige McNamara , Jamie Wagner , Suzette Blanchard , Dongrui Wang , Christine Brown
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Cellular Immmunotherapy
Clinical Trial Registration Number
NCT04214392
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr TPS2662)
DOI
10.1200/JCO.2021.39.15_suppl.TPS2662
Abstract #
TPS2662
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase 1b multicenter study to evaluate CHM 1101 in patients with recurrent or progressive glioblastoma.
First Author: Jason Blair Litten
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).
First Author: Changqing Xie
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A phase 1, first-in-human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors.
First Author: Kim Anna Reiss
Poster
2021 ASCO Annual Meeting
A phase 1, first in human study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors.
First Author: Joshua Bauml